When we buy critical illness insurance, we expect financial support if we become seriously ill. However, a diagnosis alone does not guarantee a payout. The condition must meet the policy’s definition, and some benefits also require a specified surgical procedure.
As medical treatment evolves, this raises a practical question: should the procedure used to treat an illness determine whether someone qualifies for a claim? The Life Insurance Association, Singapore (LIA) will explore this when its next review of severe-stage critical illness definitions begins in 2027.
Why Critical Illness Definitions Are Being Reviewed
In Parliament on 7 October 2026, Dr Hamid Razak asked whether definitions could focus more on the underlying disease and its severity, so that a different treatment approach alone would not prevent coverage. MAS chairman Gan Kim Yong said LIA would explore this for certain conditions.
LIA has standard definitions for 37 severe-stage critical illnesses, while insurers may offer additional benefits such as early-stage coverage or multiple payouts. The announced review concerns the severe-stage framework and could change how future policies assess claims. However, existing policyholders will not automatically receive updated coverage.
Why The Procedures Matter?
Critical illness insurance provides a lump sum to help with the financial consequences of illness. The payout does not depend on the size of our medical bill and can support household expenses, caregiving and other costs during recovery.
Some definitions currently use established procedures as indicators of disease severity, lengthy recovery and financial impact. In the 2027 review, LIA will consider whether certain definitions can rely less on these procedures and more on the illness itself.
The difficulty is that a less invasive treatment does not necessarily mean a minor illness. A patient could still face serious health consequences and financial disruption.
The review therefore needs to establish which medical criteria best reflect the circumstances these policies are intended to cover.
Updated Definitions Do Not Necessarily Mean Broader Coverage
A revised definition could recognise different treatment approaches while retaining a demanding severity threshold. It could also clarify existing requirements without substantially increasing the number of people who qualify.
For policyholders, the question will be whether comparable illnesses are assessed consistently despite differences in treatment. Benefits would still depend on satisfying the policy’s criteria.
Why Changes Would Apply To New Products Sold
MAS said updated definitions would apply to new products sold. Changes can affect coverage, the likelihood of claims and consequently premiums, although no specific premium changes have been announced.
In a separate parliamentary response in May 2026, the Government explained that existing policies do not automatically adopt updated definitions. Expanding coverage without corresponding premium adjustments could affect the sustainability of these products.
This creates a challenge for existing policyholders. Future buyers could gain access to policies reflecting newer treatment approaches, while people who bought cover years earlier remain subject to their original terms.
Replacing a policy may also become more difficult as someone ages or develops health conditions. Fresh underwriting could lead to additional exclusions or higher premiums, while waiting periods may apply under the replacement policy. A newer policy may therefore offer more suitable definitions without providing better overall protection.
LIA was separately studying whether existing policyholders could adjust their coverage to include newer treatments with appropriate premium changes. This could offer a route to updated protection without replacing a policy, but it remains a feasibility study rather than a confirmed option.
Read Also: Guide To Understanding How Critical Illness Policy Works
Photo Credit: iStock/Boyloso
